In the cystoscopic follow-up of non-muscle-invasive transitional cell carcinoma, NMP-22 works for high grades, but unreliable in low grades and upper urinary tract tumors.


Coskuner E. R. , Cevik I., Ozkan A., DİLLİOĞLUGİL Ö., Akdas A.

International urology and nephrology, cilt.44, ss.793-8, 2012 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 44 Konu: 3
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1007/s11255-012-0144-x
  • Dergi Adı: International urology and nephrology
  • Sayfa Sayıları: ss.793-8

Özet

Two percent of the bladder non-muscle-invasive (NMI) transitional cell carcinomas (TCC) are associated with upper urinary tract (UUT) TCC. We evaluated the role of nuclear matrix protein-22 (NMP-22) (BladderChek(A (R))) test in the diagnosis of lower urinary tract and UUT-TCC.